Notification
No new Notification messages
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Diwali Offer: MTF at just 9.99%
Iss Diwali, Investments Ko Karo 4X with our Trade Now, Pay Later (MTF) feature
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
neuland lab ltd. stock

NEULAND LAB LTD. Share Price

13829.35 -97.80 (-0.70%)
Oct 30 2024 03:30 PM Pharmaceuticals NSE: NEULANDLAB

NEULAND LAB LTD. Share Price Update

As of the latest trading session, NEULAND LAB LTD. share price is currently at 13829.35, which is down by -97.80 from its previous closing. Today, the stock has fluctuated between 13800.00 and 14100.00. Over the past year, NEULAND LAB LTD. has achieved a return of 261.79 %. In the last month alone, the return has been 12.43 %. Read More...

NEULAND LAB LTD. Performance

Day Range

Low13800.00 High14100.00
13829.35

52 Week Range

Low 3772.55 High 16524.95
13829.35

NEULAND LAB LTD. Share Price

2406

524558

NEULANDLAB

img img img img
No Data Available

Open Price

14066.25

Prev. Close

13927.15

Volume (Shares)

10553.00

Total traded value

1459.41

Upper Circuit

16712.55

Lower Circuit

11141.75

Note: The current prices & values are delayed, Login to your account for live updates.

NEULAND LAB LTD. Fundamentals


(Standalone)

Market Cap (Cr) 17742.90
PE Ratio (TTM) 53.28
Book Value / Share 994.26
Beta 0.40
ROE 26.48%
EPS (TTM) 249.53
Dividend Yield 0.10%
Net Profit Qtr (Cr) 98.34

NEULAND LAB LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 439.60
Operating Expense 334.73
Net Profit 98.34
Net Profit Margin (%) 22.37
Earnings Per Share (EPS) 76.65
EBITDA 149.26
Effective Tax Rate (%) 24.53
Particulars MAR 2024 (Values in Cr)
Revenue 385.01
Operating Expense 298.29
Net Profit 67.61
Net Profit Margin (%) 17.56
Earnings Per Share (EPS) 52.70
EBITDA 112.15
Effective Tax Rate (%) 26.57
Particulars DEC 2023 (Values in Cr)
Revenue 392.83
Operating Expense 291.15
Net Profit 80.70
Net Profit Margin (%) 20.54
Earnings Per Share (EPS) 62.90
EBITDA 122.66
Effective Tax Rate (%) 22.23
Particulars SEP 2023 (Values in Cr)
Revenue 417.75
Operating Expense 299.39
Net Profit 89.06
Net Profit Margin (%) 21.31
Earnings Per Share (EPS) 69.42
EBITDA 140.34
Effective Tax Rate (%) 26.63
Particulars JUN 2023 (Values in Cr)
Revenue 362.99
Operating Expense 281.53
Net Profit 62.22
Net Profit Margin (%) 17.14
Earnings Per Share (EPS) 48.50
EBITDA 99.30
Effective Tax Rate (%) 25.48
Particulars MAR 2024 (Values in Cr)
Revenue 1558.58
Operating Expense 1170.36
Net Profit 299.60
Net Profit Margin (%) 19.22
Earnings Per Share (EPS) 233.51
EBITDA 474.46
Effective Tax Rate (%) 25.24
Particulars MAR 2023 (Values in Cr)
Revenue 1191.20
Operating Expense 985.74
Net Profit 163.12
Net Profit Margin (%) 13.69
Earnings Per Share (EPS) 127.14
EBITDA 281.06
Effective Tax Rate (%) 24.20
Particulars MAR 2022 (Values in Cr)
Revenue 951.08
Operating Expense 871.41
Net Profit 63.53
Net Profit Margin (%) 6.67
Earnings Per Share (EPS) 49.74
EBITDA 144.26
Effective Tax Rate (%) 22.27
Particulars MAR 2021 (Values in Cr)
Revenue 936.91
Operating Expense 848.05
Net Profit 80.29
Net Profit Margin (%) 8.56
Earnings Per Share (EPS) 62.58
EBITDA 162.54
Effective Tax Rate (%) 23.50
Particulars MAR 2020 (Values in Cr)
Revenue 762.71
Operating Expense 714.10
Net Profit 15.88
Net Profit Margin (%) 2.08
Earnings Per Share (EPS) 12.38
EBITDA 105.35
Effective Tax Rate (%) 69.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 993.66
ROE % 26.38
ROCE % 33.01
Total Debt to Total Equity 0.10
EBITDA Margin 30.49
Particulars MAR 2023 (Values in Cr)
Book Value / Share 769.94
ROE % 17.84
ROCE % 20.58
Total Debt to Total Equity 0.20
EBITDA Margin 23.64
Particulars MAR 2022 (Values in Cr)
Book Value / Share 650.88
ROE % 7.85
ROCE % 9.23
Total Debt to Total Equity 0.26
EBITDA Margin 15.21
Particulars MAR 2021 (Values in Cr)
Book Value / Share 608.98
ROE % 9.48
ROCE % 11.10
Total Debt to Total Equity 0.30
EBITDA Margin 16.02
Particulars MAR 2020 (Values in Cr)
Book Value / Share 549.68
ROE % 2.30
ROCE % 7.56
Total Debt to Total Equity 0.35
EBITDA Margin 13.87
Particulars MAR 2024 (Values in Cr)
Book Value / Share 988.88
ROE % 26.48
ROCE % 33.13
Total Debt to Total Equity 0.10
EBITDA Margin 30.44
Particulars MAR 2023 (Values in Cr)
Book Value / Share 765.49
ROE % 17.90
ROCE % 20.64
Total Debt to Total Equity 0.20
EBITDA Margin 23.59
Particulars MAR 2022 (Values in Cr)
Book Value / Share 647.06
ROE % 7.86
ROCE % 9.24
Total Debt to Total Equity 0.26
EBITDA Margin 15.17
Particulars MAR 2021 (Values in Cr)
Book Value / Share 605.44
ROE % 9.49
ROCE % 11.12
Total Debt to Total Equity 0.30
EBITDA Margin 15.98
Particulars MAR 2020 (Values in Cr)
Book Value / Share 546.26
ROE % 2.27
ROCE % 7.55
Total Debt to Total Equity 0.35
EBITDA Margin 13.81
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 116.79
Total Assets 1832.56
Total Liabilities 1832.56
Total Equity 1282.70
Share Outstanding 12829889
Price to Book Ratio 6.35
Return on Assets (%) 16.37
Return on Capital (%) 21.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 59.10
Total Assets 1579.76
Total Liabilities 1579.76
Total Equity 994.09
Share Outstanding 12829889
Price to Book Ratio 2.35
Return on Assets (%) 10.35
Return on Capital (%) 14.66
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 20.35
Total Assets 1383.48
Total Liabilities 1383.48
Total Equity 840.50
Share Outstanding 12829889
Price to Book Ratio 1.59
Return on Assets (%) 4.61
Return on Capital (%) 5.96
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 19.39
Total Assets 1324.78
Total Liabilities 1324.78
Total Equity 786.45
Share Outstanding 12829889
Price to Book Ratio 3.45
Return on Assets (%) 6.08
Return on Capital (%) 8.43
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 46.98
Total Assets 1230.97
Total Liabilities 1230.97
Total Equity 709.95
Share Outstanding 12829889
Price to Book Ratio 0.52
Return on Assets (%) 1.31
Return on Capital (%) 1.7
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 115.28
Total Assets 1830.92
Total Liabilities 1830.92
Total Equity 1276.53
Share Outstanding 12829889
Price to Book Ratio 6.35
Return on Assets (%) 16.36
Return on Capital (%) 22.04
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 58.64
Total Assets 1579.33
Total Liabilities 1579.33
Total Equity 988.36
Share Outstanding 12829889
Price to Book Ratio 2.35
Return on Assets (%) 10.32
Return on Capital (%) 14.7
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 18.98
Total Assets 1382.12
Total Liabilities 1382.12
Total Equity 835.57
Share Outstanding 12829889
Price to Book Ratio 1.59
Return on Assets (%) 4.59
Return on Capital (%) 5.96
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.07
Total Assets 1323.52
Total Liabilities 1323.52
Total Equity 781.88
Share Outstanding 12829889
Price to Book Ratio 3.45
Return on Assets (%) 6.06
Return on Capital (%) 8.43
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 45.69
Total Assets 1229.74
Total Liabilities 1229.74
Total Equity 705.54
Share Outstanding 12829889
Price to Book Ratio 0.52
Return on Assets (%) 1.29
Return on Capital (%) 1.67
Particulars MAR 2024 (Values in Cr)
Net Income 401.43
Cash from Operations 372.78
Cash from Investing -149.68
Cash from Financing -69.28
Net change in Cash 42.20
Free Cash Flow 516.45
Particulars MAR 2023 (Values in Cr)
Net Income 215.74
Cash from Operations 280.83
Cash from Investing -61.49
Cash from Financing -135.79
Net change in Cash 39.91
Free Cash Flow 346.96
Particulars MAR 2022 (Values in Cr)
Net Income 82.16
Cash from Operations 80.88
Cash from Investing -95.51
Cash from Financing 37.72
Net change in Cash 2.59
Free Cash Flow 178.56
Particulars MAR 2021 (Values in Cr)
Net Income 105.33
Cash from Operations 194.63
Cash from Investing -84.42
Cash from Financing -113.66
Net change in Cash -8.72
Free Cash Flow 300.03
Particulars MAR 2020 (Values in Cr)
Net Income 52.92
Cash from Operations 62.02
Cash from Investing -48.67
Cash from Financing -5.48
Net change in Cash 3.18
Free Cash Flow 110.82
Particulars MAR 2024 (Values in Cr)
Net Income 400.76
Cash from Operations 371.62
Cash from Investing -149.67
Cash from Financing -69.28
Net change in Cash 41.10
Free Cash Flow 515.28
Particulars MAR 2023 (Values in Cr)
Net Income 215.21
Cash from Operations 282.09
Cash from Investing -61.49
Cash from Financing -135.79
Net change in Cash 41.23
Free Cash Flow 348.22
Particulars MAR 2022 (Values in Cr)
Net Income 81.73
Cash from Operations 80.93
Cash from Investing -95.52
Cash from Financing 37.72
Net change in Cash 2.60
Free Cash Flow 178.62
Particulars MAR 2021 (Values in Cr)
Net Income 104.96
Cash from Operations 194.46
Cash from Investing -84.41
Cash from Financing -113.65
Net change in Cash -8.79
Free Cash Flow 299.85
Particulars MAR 2020 (Values in Cr)
Net Income 52.49
Cash from Operations 61.33
Cash from Investing -48.67
Cash from Financing -5.47
Net change in Cash 2.47
Free Cash Flow 110.12
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 54.89 35.64 3.06 420.64 35.27 / 77.70
BLISS GVS PHARMA LTD 123.65 15.48 1.28 1302.06 82.60 / 148.95
CIPLA LTD 1478.10 25.86 4.20 119370.68 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 301.10 0.00 3.06 886.17 144.45 / 332.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 54.89 83.17 10.43 420.64 35.27 / 77.70
AMRUTAJAN HEALTH LTD 726.95 49.35 7.28 2101.66 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 7386.55 140.96 25.93 18466.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 123.65 16.10 1.27 1302.06 82.60 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 13807.60
  • 26 Days 13531.20
  • 10 Days 14193.50
  • 50 Days 13018.30
  • 12 Days 14082.30
  • 100 Days 11177.20
  • 20 Days 13614.90
  • 200 Days 5988.70
13968.82
PIVOT
First Resistance 14158.33
Second Resistance 14389.52
Third Resistance 14579.03
First Support 13737.63
Second Support 13548.12
Third Support 13316.93
RSI 62.60
MACD 551.06
Commodity Channel Index (CCI) 29.35
ADX 15.75
Williams % R -53.43

Over 1 Month

down

12.43

Over 3 Months

down

65.46

Over 6 Months

down

93.48

Over 1 Year

down

261.79

Over 3 Years

down

102.79

Over 5 Years

down

94.96

NEULAND LAB LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

NEULAND LAB LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
36.85
Promoter Holdings
32.64
FII
26.46
DII
4.03
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ramamohan Rao Davuluri Shareholding of Promoter and Promoter Group 2769974.0 21.59
Malabar India Fund Limited Public Shareholding 780639.0 6.08
Davuluri Vijaya Rao Shareholding of Promoter and Promoter Group 613338.0 4.78
Smallcap World Fund, Inc Public Shareholding 483087.0 3.77
Mukul Mahavir Agrawal Public Shareholding 400000.0 3.12
Davuluri Sucheth Rao Shareholding of Promoter and Promoter Group 337542.0 2.63
Hsbc Small Cap Fund Public Shareholding 328322.0 2.56
Davuluri Saharsh Rao Shareholding of Promoter and Promoter Group 287087.0 2.24
Matthews India Fund Public Shareholding 225910.0 1.76
Siddharth Iyer Public Shareholding 217065.0 1.69
Jupiter India Fund Public Shareholding 143422.0 1.12
Kedia Securities Private Limited Public Shareholding 130000.0 1.01
Davuluri Rohini Niveditha Rao Shareholding of Promoter and Promoter Group 85780.0 0.67
Usha Rani Reddy Chevalla Shareholding of Promoter and Promoter Group 34634.0 0.27
Gannabathula Venkata Krishna Rama Rao Shareholding of Promoter and Promoter Group 32027.0 0.25
Gannabathula Veeravenkata Satyanarayanamurty Shareholding of Promoter and Promoter Group 21223.0 0.17
Gannabathula Uma Bala Shareholding of Promoter and Promoter Group 6409.0 0.05
Suryanarayana M Siram Shareholding of Promoter and Promoter Group 100.0 0.0
Velugubanti S Prasadarao Shareholding of Promoter and Promoter Group 100.0 0.0

NEULAND LAB LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-11 10.0 Final 2023-07-12 Equity shares 2022-07-14 5.0 Final 2022-07-15 Equity shares 2021-06-29 3.0 Final 2021-07-01 Equity shares 2020-11-10 2.0 Interim 2020-11-11 Equity shares 2020-02-18 2.0 Interim 2020-02-20 Equity shares 2019-06-27 1.2 Final 2019-06-29 Equity shares 2016-08-04 2.0 Final 2016-08-08 Equity shares 2015-08-06 1.5 Final 2015-08-08 Equity shares 2014-06-16 1.5 Final 2014-06-18 Equity shares 2014-06-16 1.5 Special 2014-06-18 Equity shares 2013-07-24 1.2 Final 2013-07-26 Equity shares 2009-07-13 3.5 Final 2009-07-15 Equity shares 2008-07-17 2.5 Final 2008-07-21 Equity shares 2007-07-11 2.5 Final 2007-07-13 Equity shares 2005-07-20 0.0 Final 2005-07-22 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About NEULAND LAB LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by NEULAND LAB LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Neuland Laboratories Ltd?

Answer Field

The share price of Neuland Laboratories Ltd for NSE is ₹ 13829.35 and for BSE is ₹ 13806.05.

What is the Market Cap of Neuland Laboratories Ltd?

Answer Field

The market cap of Neuland Laboratories Ltd for NSE is ₹ 1,77,42.90 Cr. and for BSE is ₹ 1,77,13.01 Cr. as of now.

What is the 52 Week High and Low of Neuland Laboratories Ltd?

Answer Field

The 52 Week High and Low of Neuland Laboratories Ltd for NSE is ₹ 16524.95 and ₹ 3772.55 and for BSE is ₹ 16501.00 and ₹ 3775.00.

How to Buy Neuland Laboratories Ltd share?

Answer Field

You can trade in Neuland Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Neuland Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 261.79%.

What is the Current Share Price of Neuland Laboratories Ltd?

Answer Field

Neuland Laboratories Ltd share price is for NSE ₹ 13829.35 & for BSE ₹ 13806.05 as on Oct 30 2024 03:30 PM.

What is the Market Cap of Neuland Laboratories Ltd Share?

Answer Field

The market cap of Neuland Laboratories Ltd for NSE ₹ 1,77,42.90 & for BSE ₹ 1,77,13.01 as on Oct 30 2024 03:30 PM.

What is the P/E Ratio of Neuland Laboratories Ltd Share?

Answer Field

As on Oct 30 2024 03:30 PM the price-to-earnings (PE) ratio for Neuland Laboratories Ltd share is 53.28.

What is the PB ratio of Neuland Laboratories Ltd Share?

Answer Field

As on Oct 30 2024 03:30 PM, the price-to-book (PB) ratio for Neuland Laboratories Ltd share is 994.26.

How to Buy Neuland Laboratories Ltd Share?

Answer Field

You can trade in Neuland Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Neuland Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Neuland Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Neuland Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader